Canada Pension Plan Investment Board’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-606,890
Closed -$64.6M 1426
2024
Q2
$64.6M Buy
+606,890
New +$60.9M 0.06% 243
2020
Q3
Sell
-50,177
Closed -$4.38M 1268
2020
Q2
$4.38M Buy
+50,177
New +$4.33M 0.01% 549
2019
Q2
Sell
-15,178
Closed -$1.31M 1407
2019
Q1
$1.31M Sell
15,178
-40,622
-73% -$3.26M ﹤0.01% 1071
2018
Q4
$4.29M Buy
+55,800
New +$4.34M 0.01% 812
2013
Q4
Sell
-30,707
Closed -$2.11M 1255
2013
Q3
$2.11M Buy
+30,707
New +$2.03M 0.01% 656

Other funds holding NVS

Canada Pension Plan Investment Board's NVS Position: Q3 2024 in Review

Canada Pension Plan Investment Board sold out of Novartis (NVS) in Q3 2024, closing a stake of 606,890 shares — an estimated $64.6M sold.

Canada Pension Plan Investment Board first reported a position in NVS in Q3 2013 and held it in 5 quarters. The position peaked at $64.6M in Q2 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Canada Pension Plan Investment Board reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 606,890 Novartis shares in Q3 2024, an estimated $64.6M.
  • Canada Pension Plan Investment Board first reported a position in Novartis in Q3 2013 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's Novartis position peaked at $64.6M in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.